Sweden: Pernilla Sandwall leaves InDex Pharma for CEO role at WntResearch

Pernilla Sandwall, incoming CEO at WntResearch

Pernilla Sandwall is to leave her COO position at InDex Pharmaceuticals Holding to become CEO of WntResearch, a biotech company in oncology developing new therapies intended to prevent the metastatic process. Sandwall, who takes up the WntResearch position on April 29, replaces current acting CEO Anders Rabbe  who is leaving on February 15 at his…

You must be a HMI Subscriber to view this content.

Subscribe Now »